Cargando…

P1150: REAL WORLD DATA ON BORTEZOMIB-BASED THERAPY IN WALDENSTRÖM’S MACROGLOBULINAEMIA: EFFECTIVE EVEN IN MULTIPLY TREATED PATIENTS INCLUDING PRIOR BTK-INHIBITORS

Detalles Bibliográficos
Autores principales: Uppal, E., Khwaja, J., Rismani, A., Kyriakou, C., D’Sa, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429004/
http://dx.doi.org/10.1097/01.HS9.0000847468.19439.37
_version_ 1784779296382910464
author Uppal, E.
Khwaja, J.
Rismani, A.
Kyriakou, C.
D’Sa, S.
author_facet Uppal, E.
Khwaja, J.
Rismani, A.
Kyriakou, C.
D’Sa, S.
author_sort Uppal, E.
collection PubMed
description
format Online
Article
Text
id pubmed-9429004
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94290042022-08-31 P1150: REAL WORLD DATA ON BORTEZOMIB-BASED THERAPY IN WALDENSTRÖM’S MACROGLOBULINAEMIA: EFFECTIVE EVEN IN MULTIPLY TREATED PATIENTS INCLUDING PRIOR BTK-INHIBITORS Uppal, E. Khwaja, J. Rismani, A. Kyriakou, C. D’Sa, S. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429004/ http://dx.doi.org/10.1097/01.HS9.0000847468.19439.37 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Uppal, E.
Khwaja, J.
Rismani, A.
Kyriakou, C.
D’Sa, S.
P1150: REAL WORLD DATA ON BORTEZOMIB-BASED THERAPY IN WALDENSTRÖM’S MACROGLOBULINAEMIA: EFFECTIVE EVEN IN MULTIPLY TREATED PATIENTS INCLUDING PRIOR BTK-INHIBITORS
title P1150: REAL WORLD DATA ON BORTEZOMIB-BASED THERAPY IN WALDENSTRÖM’S MACROGLOBULINAEMIA: EFFECTIVE EVEN IN MULTIPLY TREATED PATIENTS INCLUDING PRIOR BTK-INHIBITORS
title_full P1150: REAL WORLD DATA ON BORTEZOMIB-BASED THERAPY IN WALDENSTRÖM’S MACROGLOBULINAEMIA: EFFECTIVE EVEN IN MULTIPLY TREATED PATIENTS INCLUDING PRIOR BTK-INHIBITORS
title_fullStr P1150: REAL WORLD DATA ON BORTEZOMIB-BASED THERAPY IN WALDENSTRÖM’S MACROGLOBULINAEMIA: EFFECTIVE EVEN IN MULTIPLY TREATED PATIENTS INCLUDING PRIOR BTK-INHIBITORS
title_full_unstemmed P1150: REAL WORLD DATA ON BORTEZOMIB-BASED THERAPY IN WALDENSTRÖM’S MACROGLOBULINAEMIA: EFFECTIVE EVEN IN MULTIPLY TREATED PATIENTS INCLUDING PRIOR BTK-INHIBITORS
title_short P1150: REAL WORLD DATA ON BORTEZOMIB-BASED THERAPY IN WALDENSTRÖM’S MACROGLOBULINAEMIA: EFFECTIVE EVEN IN MULTIPLY TREATED PATIENTS INCLUDING PRIOR BTK-INHIBITORS
title_sort p1150: real world data on bortezomib-based therapy in waldenström’s macroglobulinaemia: effective even in multiply treated patients including prior btk-inhibitors
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429004/
http://dx.doi.org/10.1097/01.HS9.0000847468.19439.37
work_keys_str_mv AT uppale p1150realworlddataonbortezomibbasedtherapyinwaldenstromsmacroglobulinaemiaeffectiveeveninmultiplytreatedpatientsincludingpriorbtkinhibitors
AT khwajaj p1150realworlddataonbortezomibbasedtherapyinwaldenstromsmacroglobulinaemiaeffectiveeveninmultiplytreatedpatientsincludingpriorbtkinhibitors
AT rismania p1150realworlddataonbortezomibbasedtherapyinwaldenstromsmacroglobulinaemiaeffectiveeveninmultiplytreatedpatientsincludingpriorbtkinhibitors
AT kyriakouc p1150realworlddataonbortezomibbasedtherapyinwaldenstromsmacroglobulinaemiaeffectiveeveninmultiplytreatedpatientsincludingpriorbtkinhibitors
AT dsas p1150realworlddataonbortezomibbasedtherapyinwaldenstromsmacroglobulinaemiaeffectiveeveninmultiplytreatedpatientsincludingpriorbtkinhibitors